The FDA has scheduled a meeting on Dec. 10 with its Vaccines and Related Biological Products Advisory Committee to discuss Pfizer’s request for emergency use authorization.https://t.co/uzuKWHog63— KXAN News (@KXAN_News) November 21, 2020
The FDA has scheduled a meeting on Dec. 10 with its Vaccines and Related Biological Products Advisory Committee to discuss Pfizer’s request for emergency use authorization.https://t.co/uzuKWHog63